Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee J Helman

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Annual Review of Medicine|January 18, 2006
Molecular approaches in pediatric oncologyChand Khanna, Lee J Helman
JAMA Oncology|January 30, 2016
Precision Therapy for Pediatric CancersJaved Khan, Lee J Helman
Neoplasia (New York, N.Y.)|August 23, 2002
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathwayXiaolin Wan, Lee J Helman
Nature Reviews. Cancer|September 3, 2003
Mechanisms of sarcoma developmentLee J Helman, Paul Meltzer
Oncogene|November 7, 2003
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cellsXiaolin Wan, Lee J Helman
The Oncologist|September 4, 2007
The biology behind mTOR inhibition in sarcomaXiaolin Wan, Lee J Helman
Pharmacology & Therapeutics|October 23, 2012
Prospects and challenges for the development of new therapies for Ewing sarcomaPatrick J Grohar, Lee J Helman
Hematology/Oncology Clinics of North America|April 24, 2012
Targeting the insulin growth factor receptor 1Fernanda I Arnaldez, Lee J Helman
The New England Journal of Medicine|November 24, 2021
New Horizons in the Treatment of OsteosarcomaPaul S Meltzer, Lee J Helman
Cancer Treatment and Research|March 10, 2010
Strategies to explore new approaches in the investigation and treatment of osteosarcomaSu Young Kim, Lee J Helman
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Annual Review of Medicine|January 18, 2006
Molecular approaches in pediatric oncologyChand Khanna, Lee J Helman
JAMA Oncology|January 30, 2016
Precision Therapy for Pediatric CancersJaved Khan, Lee J Helman
Neoplasia (New York, N.Y.)|August 23, 2002
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathwayXiaolin Wan, Lee J Helman
Nature Reviews. Cancer|September 3, 2003
Mechanisms of sarcoma developmentLee J Helman, Paul Meltzer
Oncogene|November 7, 2003
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cellsXiaolin Wan, Lee J Helman
The Oncologist|September 4, 2007
The biology behind mTOR inhibition in sarcomaXiaolin Wan, Lee J Helman
Pharmacology & Therapeutics|October 23, 2012
Prospects and challenges for the development of new therapies for Ewing sarcomaPatrick J Grohar, Lee J Helman
Hematology/Oncology Clinics of North America|April 24, 2012
Targeting the insulin growth factor receptor 1Fernanda I Arnaldez, Lee J Helman
The New England Journal of Medicine|November 24, 2021
New Horizons in the Treatment of OsteosarcomaPaul S Meltzer, Lee J Helman
Cancer Treatment and Research|March 10, 2010
Strategies to explore new approaches in the investigation and treatment of osteosarcomaSu Young Kim, Lee J Helman
Pageof 10